SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With Primary Immunodeficiencies
The Journal of Infectious Diseases · 04.08.2023 · 228 (Supplement_1) · S24-S33
DOI: 10.1093/infdis/jiad145 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 04.08.2023. Verfasst von Robert Paris. Beteiligte Einrichtung: Moderna, Inc., Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ModernaTX Inc.
Abstract (Originalsprache)
Primary immunodeficiencies (PIDs) are heterogeneous, rare disorders that increase susceptibility to infection and/or immune dysregulation. Individuals with certain PIDs are at high risk of severe or fatal outcomes from SARS-CoV-2 infections (the causative agent of COVID-19), either due to the underlying PID and/or due to the presence of comorbidities such as severe lung and liver disease. Vaccination remains the primary strategy to protect individuals with PID from COVID-19. However, populations with PID exhibit variable vaccine seroresponse rates, antibody titers, and neutralization activity depending on the type of PID and/or COVID-19 vaccine, and consequently, are at an elevated risk of severe disease. In this article, we review the COVID-19 burden in patients with PIDs and focus in-depth on findings from patients with predominantly antibody deficiencies or combined immunodeficiencies. We conclude by providing COVID-19 vaccination recommendations for this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Moderna, Inc., Cambridge, Massachusetts, USA.
- Department of Medicine, Infectious Diseases, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Förderung
- ModernaTX Inc
Zitieren
APA
Paris, R. (2023). SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With Primary Immunodeficiencies. The Journal of Infectious Diseases, 228(Supplement_1), S24-S33. https://doi.org/10.1093/infdis/jiad145
Vancouver
Paris R. SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With Primary Immunodeficiencies. The Journal of Infectious Diseases. 2023;228(Supplement_1):S24-S33. doi:10.1093/infdis/jiad145
BibTeX
@article{Paris2023,
author = {Paris, Robert},
title = {SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With Primary Immunodeficiencies},
journal = {The Journal of Infectious Diseases},
year = {2023},
volume = {228},
number = {Supplement_1},
pages = {S24--S33},
doi = {10.1093/infdis/jiad145}
}
EUVIMED